A role for cognitive behavioral therapy in treatment-resistant depression

Only a third of patients with depression respond fully to antidepressant drugs, and little evidence exists regarding the best next-step treatment for patients with resistant symptoms. Researchers in the CoBalT study (Cognitive Behavioural Therapy) at the University of Bristol in England examined cognitive behavioral therapy (CBT) as an adjunct to usual care (including pharmacotherapy) for … Continue reading A role for cognitive behavioral therapy in treatment-resistant depression

CBT and the risk for heart disease

Psychosocial factors are associated with increased risk of cardiovascular disease morbidity and mortality, but the effects of psychosocial factor treatment on heart disease are uncertain. Researchers at Uppsala University Hospital, in Sweden, studied the effects of cognitive behavioral therapy (CBT) on the recurrence of cardiovascular disease.

Effectiveness of CBT and OBT in fibromyalgia

Improvements in physical functioning, pain, and distress, have been reported in patients receiving operant-behavioral (OBT) or cognitive behavioral treatments (CBT) for the fibromyalgia syndrome. And the benefits lasted for 12 months (the end of the study) compared to another group that received placebo therapy. Wow! Impressive, considering there’s no FDA-approved treatment for fibromyalgia. But what … Continue reading Effectiveness of CBT and OBT in fibromyalgia